NVAX Stock Pops as the WHO Grants Novavax's Vaccine Emergency Use. 8 Things to Know.InvestorPlace • 12/17/21
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 VaccinePRNewsWire • 12/17/21
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 VaccinePRNewsWire • 12/16/21
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc.Newsfile Corp • 12/16/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors to Lead Plaintiff Opportunity in Securities Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 12/15/21
NVAX Investor Alert: Thornton Law Firm Reminds Novavax, Inc. Investors of Securities Class Action LawsuitNewsfile Corp • 12/15/21
Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the FirmPRNewsWire • 12/15/21
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Novavax, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVAXPRNewsWire • 12/14/21
Serum Institute's CEO Expects To Launch Novavax Vaccine For Kids In Six Months: ReutersBenzinga • 12/14/21